[Sonographic evaluation of myopathy]

Area of Science:

• Musculoskeletal imaging
• Neurology
• Rheumatology

Background:

• Muscle fiber imaging is crucial for diagnosing myopathy.
• Ultrasonography (US) provides rapid, whole-body muscle assessment, surpassing MRI and CT in accessibility.
• Myopathy imaging reveals diffuse changes (e.g., echo signal alterations in muscular dystrophy, myositis) and focal findings (e.g., masses in sarcoid myopathy).

Purpose of the Study:

• To highlight the utility of ultrasonography in evaluating skeletal muscle abnormalities in patients with suspected myopathy.
• To emphasize US's role in guiding muscle biopsy site selection for accurate diagnosis.
• To explore the correlation between sonographic findings and clinical/other imaging data.

Main Methods:

• Utilized ultrasonography (US) for imaging skeletal muscles.
• Assessed diffuse and focal US findings characteristic of various myopathies.
• Correlated US findings with clinical presentation and other imaging modalities (implied).

Main Results:

• Ultrasonography effectively visualizes diffuse changes (increased/decreased echo signal) and focal lesions (masses, preferential involvement) in myopathies.
• US findings vary depending on the specific myopathy, such as muscular dystrophy, myositis, sarcoid myopathy, and inclusion body myositis.
• US evaluation is beneficial for identifying appropriate sites for muscle biopsy.

Conclusions:

• Ultrasonography is a valuable, rapid imaging tool for the initial assessment of suspected myopathies.
• US findings can guide clinicians in selecting optimal biopsy locations, ensuring diagnostic adequacy.
• Further research is warranted to establish comprehensive correlations between US findings, clinical data, and other imaging techniques.